Almost periodic solutions for a class of Liénard-type systems with continuously distributed delays

Bingwen Liu

DOI: https://doi.org/10.1016/j.mcm.2006.11.023

2007-09-01

Mathematical and Computer Modelling

Abstract:

What problem does this paper attempt to address?

Clinical Observation of Simple Drug Coated Balloon Angioplasty in the Treatment of Coronary Bifurcation Lesions

Hao ZHENG,Zhan-lu LI,Guo-sheng FU

DOI: https://doi.org/10.3969/j.issn.1009-816x.2017.03.04

2017-01-01

Abstract:Objective To investigate the safety and efficacy of side branch treatment with drug coated balloon (DCB) in coronary bifurcation lesions.Methods 31 patients with bifurcation lesions in Department of Cardiology of our hospital from November 2014 to July 2016 were selected in this study (main branches stenosis ＜ 50％,branch stenosis ＞ 70％;cahber of branch vessel≥2mm) and treated with simple DCB in branch vessel.The success rate of operation,blood flow of the branch vessels and incidence of comphcations were observed.Quantitifying coronary angiography (QCA) analysis was done after 9 months and the major adverse cardiovascular events (MACE) were recorded during 9 months' follow-up as well.Results Of 33 coronary bifurcation lesions in 31 patients,57.58％ were located in left anterior descending artery/diagonal branches,30.30％ were located in circumflex aaery/obtuse marginal branches,and 12.12％ were located in right coronary artery/posterior descending artery or posterior branch of left ventricle.31 patiems successfully completed the imervemional treatment of bifurcation lesions with 100％ success rate.All the procedure was transradial approach.Branch vascular dissection was found only in two cases (one with TIMI flow grade ＜ 2) and drug-eluting stents were used as the remedial measure.During perioperative and postoperative clinical visit (outpatient or telephone follow-up),no MCAE such as death or acute myocardial infarction (AMI) occurred.Angiographic follow-up was finished in 74.19％ of the patients.There was only one patient underwem target lesion revascularization (TLR).Late lumen loss (LLL) was (0.13 ± 0.25) mm.Condusions It is a safe and effective strategy to use DCB as a standalone procedure for side branch in patients with coronary bifurcation lesions.
[Treatment of coronary bifurcation lesions with 6F-guiding catheter by transradial approach].

Bin-quan Zhou,Guo-sheng Fu,Yong Sun

DOI: https://doi.org/10.3785/j.issn.1008-9292.2009.02.015

2009-01-01

Abstract:OBJECTIVE:To investigate the feasibility and safety in treatment of coronary bifurcation lesions with 6F-guiding catheter by transradial approach. METHODS:Clinical data of 1258 patients who were treated with 6F-guiding catheter by transradial approach from Oct. 2003 to Feb. 2007 were reviewed. The most common approach in the treatment of bifurcations was one-stent technique on the main branch; if the side branch was large enough and the lesion was involved in the ostium and proximal part of side branch, two-stent technique was used. RESULT:Of 295 bifurcation lesions, 204 were originally planed to be treated by one stent; but finally 2 side branches were provisional stented due to dissection in this group. Ninety-one cases were planed to use double-stent technique: 73 with crushing stent (46 step crushing, 24 modified balloon crushing, 3 reverse crushing), 5 with T-stent, 3 with Cullote-stent, 5 with modified V-stent, 5 with step kissing stent. There was no acute myocardial infarction or death occurred but 1 case was complicated with cardiac tamponade secondary from coronary perforation. CONCLUSION:The treatment of coronary bifurcation lesions with 6F-guiding catheter by transradial approach is a feasible and safe procedure.
Effect of Balloon Embedded Bifurcating Stenting with Single Stent Strategy for Side Branch Protection

Bishnu Pada Saha,Mir Jamal Uddin,Sabina Hashem,Priyanka Adhikary,Mohammad Arifur Rahman,C M Kudrat E Khuda,Saqif Shahriar,Mahmudul Hasan,Mizanur Rahman Majumder,Farzana Sultana,Whaiduzzaman Jewel

DOI: https://doi.org/10.3329/bhj.v36i1.55513

2021-09-20

Bangladesh Heart Journal

Abstract:Background: Intervention for bifurcation lesions is associated with increased risk of adverse events and includes acute side branch (SB) occlusion during main branch (MB) stenting. This acute occlusion of side branch can often be catastrophic for the patient. We here in describe our experience in National Institute of Cardiovascular Diseases and Hospital (NICVD), Dhaka, Bangladesh with a technique which can be incorporated into bifurcation stenting to reduce or almost eliminate the incidence of side branch occlusion or catastrophe. Methods: A prospective, observational, non-blinded study in patients from a single tertiary referral cardiac center National Institute of Cardiovascular Diseases & Hospital (NICVD), Dhaka, Bangladesh. Patients with an indication for percutaneous coronary intervention (PCI) of a denovo bifurcation lesion were screened. The study included 51 patients who underwent coronary angiogram in our institution and had bifurcation lesions suitable for single stent strategy between March 2017 to September 2018. Results: 51 patients with bifurcation lesion were included in the study and underwent a balloon embedded bifurcation stenting with a semi inflated balloon placed across the SB ostium. Angiographic success was achieved in all the patients but procedural success was achieved in 88.2% of the patients. TIMI 3 flow of main branch (MB) was achieved 96.08% and side branch (SB) was achieved 88.2%. Incidence of dissection was 5.9%, acute occlusion of SB was 2.0% and MACE was 3.9%. Mean fluoroscopy time and contrast volume was similar to that of conventional bifurcation stenting. The jailed SB balloon and wire could be successfully removed in all patients. Conclusion: The present study suggests that balloon embedded bifurcation stenting with a semi inflated balloon to protect the SB is feasible, with minimal procedural adverse events and successful in minimizing or almost eliminating the incidence of acute side branch occlusion or dissection as well as MACE. Bangladesh Heart Journal 2021; 36(1): 17-23
Immunodepression by oncogenic viruses.

P. Dent

Abstract:
Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions: 4-years follow-up

D Maximkin,Z Shugushev,A Chepurnoy,E Gitelzon,A Faybushevich

DOI: https://doi.org/10.1093/eurheartj/ehab724.1434

IF: 39.3

2021-10-01

European Heart Journal

Abstract:Abstract Aim To evaluate the long-term results of the use of drug-eluting balloon catheters in patients with Left Main (LM) bifurcation stenosis. Methods The analysis involved 142 patients with true bifurcations of the Left Main. Randomization in 2 main groups: Group I (n=52) included patients, who received kissing- dilatation with traditional NC balloon catheters and Group II (n=52), who had a kissing-dilatation of the main bifurcation artery with a traditional NC balloon catheters, and a side branch - with drug-eluting balloon catheters. In retrospectively, the third (III) control group (n=38) was formed, where the two-stent technique was performed. All patients from main groups had previously performed “Provisional T” stenting and final “kissing balloons” dilation technique. Coronary angiography and OCT were performed to evaluate the results of all patients. Inclusion criteria: true LM bifurcation stenoses according to QCA and OCT; SYNTAX score <32. Primary endpoints: incidence of MACE - death, MI, re-interventions. Secondary endpoints: the incidence of restenosis and late stent thrombosis. Results The long-term results after 4-years were observe in 46 patients from Group I and 48 patients from Group II. Restenosis of the side branch of more than 50% according to QCA was detected in 12 patients (26.0%) from Group I and in 5 patients (10.4%) from Group II (p<0.05). In-stent restenosis of the main vessel of more than 50% according to QCA was detected in 4 patients (8.6%) from Group I and in 1 patients (2.1%) from Group II (p<0.05). In patients from group I, the average MLA in the side branch after 4-years compared with data after PCI was 5.58±1.34 and 4.12±1.21 mm2, respectively (p<0.05), in the main branch – 6.34±1.56 and 5.88±1.14 mm2, respectively (p>0.05). In patients from Group II, the average MLA were, respectively, 5.38±1.24 and 5.01±1.14 mm2 in side branch (p>0.05) and 6.68±1.75 and 6.36±1.22 mm2 in main branch (p>0.05). When comparing the data of MLA in the side branch in groups I and II, there was a significant difference (4.12±1.21 vs. 5.01±1.14 mm2; p<0.05).The repeat revascularization, in connection with the detected ischemia was performed in 7 patients (15.2%) from Group I and in 1 patients (2.1%) from Group II (p<0.05). In the Group I was observed non-fatal myocardial infarction in 2 patients (4.3%). The total incidence of MACE were 19.5 vs. 2.1% in groups I and II respectively (χ2=7.321; p<0.001). The survival without MACE was 97.9 and 80.5%, respectively (p=0.0219). Conclusions The use of dug-eluting balloon catheters for the “Provisional T” stenting in patients with true LM bifurcation stenosis, associated with good prognosis and demonstrated significantly lower frequency of MACE and side branch restenosis, according to OCT data, compared with patients who used traditional NC balloon catheters for “kissing-dilatation” and two-stent technique strategy. Funding Acknowledgement Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Russian academic excellence project 5-100

cardiac & cardiovascular systems
A Novel Strategy to Simplify the Procedures in Treating Complicated Coronary Bifurcation Lesions: From a Bench Test to Clinical Application

Dongdong Li,Wenshuai Ma,Pengyun Liu,Hao Liu,Baobao Bai,Mingming Zhang,Wangang Guo

DOI: https://doi.org/10.3389/fcvm.2022.854063

IF: 3.6

2022-04-01

Frontiers in Cardiovascular Medicine

Abstract:Background Although provisional stenting strategy based on jailed balloon side branch (SB) protection could be useful for high-risk bifurcation lesion in certain clinical scenarios, its complexity still gives rise to procedure complications. We proposed a novel strategy, the jailed balloon proximal optimization technique (JB-POT), to simplify the procedures in treating complex coronary bifurcation lesions (CBLs). The present study was designed to verify the safety and efficacy of JB-POT under bench testing and clinical circumstances. Methods After a stent was deployed in main vessel (MV) with a balloon jailed in SB, POT and post-dilation of the stent were performed without retrieving the jailed balloon. A re-POT was performed 2 mm away from SB branching point to minimize proximal stent malapposition. The JB-POT procedure was performed on 10 samples of a silicone bifurcation bench model, and optical coherence tomography (OCT) was utilized to evaluate stent deployment. From December 2018 to July 2021, a total of 28 consecutive patients with true CBLs treated with JB-POT were enrolled. Immediate procedure results were observed, and clinical follow-ups were performed. Results The bench test showed that JB-POT did not induce significant stent malapposition, underexpansion or distortion, as indexed by the malapposition rate, minimum stent area (MSA), eccentricity index and symmetry index determined through OCT. Under clinical circumstances, JB-POT did not induce significant malapposition, underexpansion or distortion. Among the 30 lesions, there was no primary endpoint event defined as SB occlusion, need to rewire the SB with a polymer-covered guide wire, or failure to retrieve a jailed wire or balloon. One rewiring event and 0 double stenting events occurred as secondary endpoint events. One patient died of heart failure in the 8th month after discharge. Conclusions The JB-POT protocol, which tremendously simplifies the current standard provisional stenting procedure in complicated bifurcation lesions, shows acceptability in safety and efficacy. Hence, it might become an applicable strategy for treating high-risk bifurcation lesions, especially those with multiple risked SBs.

cardiac & cardiovascular systems
Impact of stent strut link location in proximal balloon edge dilation technique for bifurcation percutaneous coronary intervention

Teruyoshi Kume,Takeshi Nishi,Yoshinobu Murasato,Satoshi Koto,Yoshitaka Sasahira,Hiroshi Okamoto,Ryotaro Yamada,Terumasa Koyama,Tomoko Tamada,Koichiro Imai,Yoji Neishi,Shiro Uemura

DOI: https://doi.org/10.1007/s12928-023-00981-4

2024-02-01

Cardiovascular Intervention and Therapeutics

Abstract:The single-stent strategy has generally been accepted as the default approach to bifurcation percutaneous coronary intervention. We have proposed the proximal balloon edge dilation (PBED) technique to prevent stent deformation during side branch (SB) dilation. This bench study aimed to evaluate the impact of stent link location and stent design on stent deformation, obstruction by stent struts at a jailed SB ostium, and incomplete stent apposition in the proximal optimization technique (POT)-PBED procedure. A coronary bifurcation model was used. We intentionally set the absence or presence of stent link on the carina (link-free or link-connect) under videoscope observation and compared stent parameters between 3- and 2-link stents ( n = 5 each, n = 20 total). In the link-free group, the SB jailing rate of 3-link stents was significantly higher than that of 2-link stents (15.5 ± 5.1% vs. 6.6 ± 1.2%, p = 0.009). In the link-connect group, the SB jailing rate of 3-link stents was significantly lower than that of 2-link stents (30.0 ± 4.5% vs. 39.0 ± 2.6%, p = 0.009). In the bifurcation segment, the rate of incomplete stent apposition was significantly lower for 3-link stents of the link-connect group than for 2-link stents of the link-connect group (3.3 ± 4.2% vs. 19.0 ± 7.8%, p = 0.009). For both stent designs, ellipticity ratio was higher for link-connect group than link-free group. Link location as well as stent cell design greatly impacted stent deformation during the POT-PBED procedure.
Novel Side Branch Ostial Stent (biguard (tm)): First-In-Man Study

Chen Shao-liang,Zhang Jun-jie,Ye Fei

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2009.18.003

2009-01-01

Abstract:Background Stenting a bifurcation lesion is technically challenging. No study has reported the clinical outcome of a dedicated bifurcation stent in China. We aimed to analyze the safety and clinical outcome of a novel side branch ostial stent (BIGUARD (TM)) stent in treating coronary bifurcation lesions.Methods Forty-seven patients were enrolled in this first-in-man study, with 61.7% true bifurcation lesions (0,11,11 and 1,1,1) and 26.7% diabetes. A two-stent technique was used in 27.6% of the patients, and 64.7% of patients crossed from the one-stent technique to the two-stent arm. Clinical and angiographic follow-up data at 12 months were available in all the 47 patients and in 43 patients (91.9%), respectively. The study endpoint was the occurrence of major adverse cardiac events (MACE) at 12 months.Results Only one patient had a non-ST segment elevation myocardial infarction, which led to 2% of the in-hospital composite MACE. Notably, the target lesion revascularization at 12 months was 8.6%, with a 10.6% composite MACE at 12 months. Neither cardiac death nor stent thrombosis was seen during the follow-up. By quantitative coronary analysis, the restenosis rate at the main vessel and ostium of the side branch was 9.4% and 2.1%, respectively. Four of 12 patients (33.3%) treated with one-stent and kissing balloon inflation had restenosis in the main vessel.Conclusion BIGUARD (TM) stent was safe and feasible in treatment of bifurcation lesions. Chin Med J 2009;122(18)2092-2096
Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trial

Xiao-Fei Gao,Zhen Ge,Jing Kan,Xiang-Quan Kong,Yan Wang,Chun-Guang Qiu,Damras Tresukosol,Yu-Quan He,Qiang Wu,Ji-Fu Li,Hai-Tao Yuan,Chengxing Shen,Xiang Chen,Muhammad Munawar,Bashir Hanif,Teguh Santoso,Eun-Seok Shin,Imad Sheiban,Fei Ye,Jun-Jie Zhang,Shao-Liang Chen

DOI: https://doi.org/10.1136/bmjopen-2021-052788

IF: 3.006

2022-03-01

BMJ Open

Abstract:Introduction Provisional stenting using drug-eluting stent is effective for simple coronary bifurcation lesions. Kissing balloon inflation using conventional non-compliant balloon is the primary treatment of side branch (SB) after main vessel (MV) stenting. Drug-coating balloon (DCB) is reported to be associated with less frequent clinical events in in-stent restenosis and small vessel disease. The importance of DCB in bifurcation treatment is understudied. Accordingly, this trial is designed to investigate the superiority of DCB to non-compliant balloon angioplasty for SB after provisional stenting in patients with true coronary bifurcation lesions. Methods and analysis The DCB-BIF trial is a prospective, multicentre, randomised, superiority trial including 784 patients with true coronary bifurcation lesions. Patients will be randomised in a 1:1 fashion to receive either DCB or non-compliant balloon angioplasty if SB diameter stenosis >70% after MV stenting. The primary endpoint is the composite of major adverse cardiac event at the 1-year follow-up, including cardiac death, myocardial infarction (MI) or clinically driven target lesion revascularisation. The major secondary endpoints include all-cause death, periprocedural MI, spontaneous MI, clinically driven target vessel revascularisation, in-stent restenosis, stroke and individual component of the primary endpoint. The safety endpoint is the risk of stent thrombosis. Ethics and dissemination The study protocol and informed consent have been reviewed and approved by the Institutional Review Board of all participating centres. The written informed consent for participation in the trial will be obtained from all participants. The results of this study will be published in a peer-reviewed journal and disseminated at conferences. Trial registration number NCT04242134 .

medicine, general & internal
Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: the Multicenter Randomized DCB-BIF Trial.

Xiaofei Gao,Nailiang Tian,Jing Kan,Ping Li,Mian Wang,Imad Sheiban,Filippo Figini,Jianping Deng,Xiang Chen,Teguh Santoso,Eun-Seok Shin,Muhammad Munawar,Shangyu Wen,Zhengzhong Wang,Shaoping Nie,Yue Li,Tan Xu,Bin Wang,Fei Ye,Junjie Zhang,Xiling Shou,Shao-Liang Chen

DOI: https://doi.org/10.1016/j.jacc.2024.08.067

IF: 24

2024-01-01

Journal of the American College of Cardiology

Abstract:BACKGROUND:Side branch stenting is often required during provisional stenting, leading to suboptimal results. Drug-coated balloons (DCB) for the compromised side branch have emerged as an attractive strategy. However, the benefit of DCB for coronary bifurcations remains unclear. OBJECTIVES:This study aimed to investigate whether DCB, compared with a noncompliant balloon (NCB), for the pinched side branch improves the outcomes of provisional stenting in patients with simple, true coronary bifurcations. METHODS:In this multicenter, randomized controlled trial, patients with true coronary bifurcations who had side branch diameter stenosis of ≥70% after main vessel stenting at 22 centers in China, Indonesia, Italy, and Korea were randomly assigned to either DCB or NCB intervention. The primary endpoint was major adverse cardiac events, a composite of cardiac death, target vessel myocardial infarction, or clinically driven target-lesion revascularization at the 1-year follow-up. RESULTS:Between September 8, 2020, and June 2, 2023, 784 patients with true coronary bifurcation lesions undergoing main vessel stenting and having a severely compromised side branch were randomly assigned to the DCB (n = 391) or NCB (n = 393) group. One-year follow-up was completed in all patients. The primary endpoint occurred in 28 patients in the DCB group and 49 patients in the NCB group (Kaplan-Meier rate: 7.2% vs 12.5%; HR: 0.56; 95% CI: 0.35-0.88; P = 0.013), driven by a reduction in myocardial infarction. There were no significant differences between groups in procedural success, crossover to a 2-stent approach, all-cause death, revascularization, or stent thrombosis. CONCLUSIONS:In patients with simple and true coronary bifurcation lesions undergoing provisional stenting, main vessel stenting with a DCB for the compromised side branch resulted in a lower 1-year rate of the composite outcome compared with an NCB intervention for the side branch. The high rates of periprocedural myocardial infarction, which occurred early and did not lead to revascularization, are of unclear clinical significance.
Acute Angiographic and Intermediate-Term Clinical Results of Patients with Non-Left Main Coronary Bifurcation Lesions Treated with BVS by Jailed Semi-Inflated Balloon Technique and Provisional Side-Branch Stenting Strategy

Chieh-Shou Su,Keng-Hao Chang,Chih-Hung Lai,Yu-Wei Chen,Tzu-Hsiang Lin,Hung-Chih Pan,Tsun-Jui Liu,Wen-Lieng Lee

DOI: https://doi.org/10.1155/2019/9896267

2019-10-03

Journal of Interventional Cardiology

Abstract:Background . To evaluate the acute angiographic and intermediate-term clinical results of patients with non-left main (LM) coronary artery bifurcation disease (CABD) treated with BVS, as compared with those treated with DES, using the jailed semi-inflated balloon technique (JSIBT) for side branch (SB) protection and provisional stenting. Methods and Results . Sixty-eight patients with non-LM CABD who had undergone provisional one-stent implantation with SB protection by JSIBT between January 2015 and December 2017 were retrospectively enrolled. Among them, 20 patients received Absorb BVS implantation and 48 patients received DES implantation. Patients in the BVS group were younger and had higher BMI, total cholesterol, low-density lipoprotein cholesterol, and hemoglobin but had lower serum creatinine and lower prevalence of prior PCI and MI. No SB balloon rupture/entrapment occurred in either group. The incidence of SB dissection/occlusion and SB in need of rewiring or stenting was rare in both groups and showed no significant difference between them. Postinterventional TIMI flow significantly increased in both groups. The intermediate-term clinical outcomes were good in terms of incidence of target lesion failure, target lesion revascularization, target vessel revascularization, myocardial infarction, and all-cause death in both groups. Conclusion . The use of JSIBT for treating CABD with modern BVS can provide SB protection as similar as those with DES, even with higher incidence of acute SB dissection/occlusion. The immediate angiographic results and acute and intermediate-term clinical outcomes were also similar in both groups. Our study results demonstrate that JSIBT might be a safe and alternative SB protection tool for BVS in patients with complex CABD.

cardiac & cardiovascular systems
Modified Kissing Balloon Inflation Associated with Better Results after Culotte Stenting for Bifurcation Lesions: A Bench Test

Jia Liu,Li,Can Chen,Jianrui Wei,Xiwei Chen,Biao Li,Yaogui Chen,Jingyun Luo,Shao-Liang Chen

DOI: https://doi.org/10.1002/ccd.28497

IF: 2.3

2019-01-01

Catheterization and Cardiovascular Interventions

Abstract:Background Main vessel (MV) stent deformation and overstretch caused by classical kissing balloon inflation (C-KBI) using two balloons with a longer overlapping in the MV for bifurcation lesions has caused a widespread concern. Purpose This bench study tested our hypothesis that mini-KBI (M-KBI) with a shorter protrusion of side branch (SB) balloon would ascertain a better result after Culotte stenting. Methods Twenty-four coronary stents were deployed using Culotte approach in twelve bifurcation models with a bifurcation angle of 45 degrees, 3.5 mm in MV diameter, and 3.0 mm in SB diameter. After stent implantation, the final KBI were assigned to C-KBI (two kissing balloons juxtaposed within the MV stent, at least overlap for 3 mm; n = 6) and M-KBI (the proximal marker of SB balloon just sited at the level of upper edge of SB ostium; n = 6). Proximal optimization technique (POT) was performed after KBI. Stent geometry was visually evaluated based on bench photos, microscopy, videoscopy, micro-CT, and scanning electron microscopy. Stent deformation index, minimal lumen diameter, and cross-sectional area at either carina level of MV and ostium of SB were measured from optical coherence tomography (OCT). Results In Culotte technique, C-KBI was associated with visually significant stent deformation, overexpansion and the "bottleneck" effect of the MV stent, which could not be effectively rectified by POT, while M-KBI could keep the circle shape of MV stent with good stent apposition in both MV and SB stent. By quantitative measurements, deformation index of MV was 0.06 +/- 0.01 after M-KBI, significantly lower than 0.25 +/- 0.02 if C-KBI was performed. In the line in carina, compared to C-KBI, M-KBI has smaller CSA-stent/CSA-reference, which indicated a less overstretch of MV stent. However, minimal lumen diameter and cross-sectional area of SB ostium was not different in the mini-KBI group (3.0958 +/- 0.0285 mm and 7.9667 +/- 0.1741 mm), when compared those after C-KBI (3.1217 +/- 0.0772 mm and 7.9083 +/- 0.3115 mm, p > .05). Conclusions Followed by POT, M-KBI is preferable than C-KBI in preventing stent deformation, overexpansion in MV stent and could get well apposed of MV stent and well-opened SB stent as expected in a Culotte technique.
A Drug-Eluting Balloon for the Treatment of Coronary Bifurcation Lesions in the Side Branch: a Prospective Multicenter Randomized (BEYOND) Clinical Trial in China

Quan-Min Jing,Xin Zhao,Ya-Ling Han,Ling-Ling Gao,Yang Zheng,Zhan-Quan Li,Ping Yang,Hong-Liang Cong,Chuan-Yu Gao,Tie-Min Jiang,Hui Li,Jun-Xia Li,Dong-Mei Wang,Geng Wang,Zhan-Chun Cong,Zhong Zhang

DOI: https://doi.org/10.1097/cm9.0000000000000743

2020-01-01

Abstract:Abstract Background Treatment of coronary bifurcation lesions remains challenging; a simple strategy has been preferred as of late, but the disadvantage is ostium stenosis or even occlusion of the side branch (SB). Only a few single-center studies investigating the combination of a drug-eluting stent in the main branch followed by a drug-eluting balloon in the SB have been reported. This prospective, multicenter, randomized study aimed to investigate the safety and efficacy of a paclitaxel-eluting balloon (PEB) compared with regular balloon angioplasty (BA) in the treatment of non-left main coronary artery bifurcation lesions. Methods Between December 2014 and November 2015, a total of 222 consecutive patients with bifurcation lesions were enrolled in this study at ten Chinese centers. Patients were randomly allocated at a 1:1 ratio to a PEB group (n = 113) and a BA group (n = 109). The primary efficacy endpoint was angiographic target lesion stenosis at 9 months. Secondary efficacy and safety endpoints included target lesion revascularization, target vessel revascularization, target lesion failure, major adverse cardiac and cerebral events (MACCEs), all-cause death, cardiac death, non-fatal myocardial infarction, and thrombosis in target lesions. The main analyses performed in this clinical trial included case shedding analysis, base-value equilibrium analysis, effectiveness analysis, and safety analysis. SAS version 9.4 was used for the statistical analyses. Results At the 9-month angiographic follow-up, the difference in the primary efficacy endpoint of target lesion stenosis between the PEB (28.7% ± 18.7%) and BA groups (40.0% ± 19.0%) was –11.3% (95% confidence interval: –16.3% to –6.3%, P superiority <0.0001) in the intention-to-treat analysis, and similar results were recorded in the per-protocol analysis, demonstrating the superiority of PEB to BA. Late lumen loss was significantly lower in the PEB group than in the BA group (–0.06 ± 0.32 vs. 0.18 ± 0.34 mm, P < 0.0001). For intention-to-treat, there were no significant differences between PEB and BA in the 9-month percentages of MACCEs (0.9% vs. 3.7%, P = 0.16) or non-fatal myocardial infarctions (0 vs. 0.9%, P = 0.49). There were no clinical events of target lesion revascularization, target vessel revascularization, target lesion failure, all-cause death, cardiac death or target lesion thrombosis in either group. Conclusions In de novo non-left main coronary artery bifurcations treated with provisional T stenting, SB dilation with the PEB group demonstrated better angiographic results than treatment with regular BA at the 9-month follow-up in terms of reduced target lesion stenosis. Trial registration ClinicalTrials.gov, NCT02325817; https://clinicaltrials.gov
Effect of low-dose cyclophosphamide on endoplasmic reticulum stress and inflammatory reaction of acute renal ischemia reperfusion injury.

Y. Long,P. Wang,H. Sun,H. Wang,P. Chen,J. Zhao

2015-10-01

European review for medical and pharmacological sciences

Abstract:OBJECTIVE To explore the effect of low-dose cyclophosphamide (CP) on endoplasmic reticulum stress (ERS) and inflammatory reaction of acute renal ischemia reperfusion injury (IRI), providing new ideas for clinical treatment. MATERIALS AND METHODS Sixty healthy adult male mice were selected and divided randomly into sham operation group (n = 20), IRI group (n = 20 cases), and the experimental group (n = 20 cases). Mice in the experimental group were pretreated with low-dose CP and acute IRI model construction. Intercellular adhesion molecule-1 (ICAM-1) immunohistochemical staining was conducted after the 24h and the detection of CHOP protein by Western blot method. Postoperative 3h and 7 day survival rate, the results of ICAM-1 immunohistochemistry staining and the gray values of C/EBP homologous protein (CHOP) of mice were compared between the three groups. RESULTS The survival rates of mice in the IRI group and the experimental group after operation were decreased significantly (p < 0.05). However, the survival rates of mice in the experimental group were higher than that in the IRI group. The differences were significant (p < 0.05). The expression of ICAM-1 was significantly reduced (p < 0.05). The difference was statistically significant. The expression of ICAM-1 was significantly reduced (p < 0.05). The gray values of mice in the IRI group and the experimental group were significantly increased. The difference was statistically significant (p < 0.05). And the gray value in the IRI group increased more than that of the experimental group. The difference was statistically significant (p < 0.05). CONCLUSIONS The pretreatment with low-dose CP for mice with acute renal IRI can reduce effectively the ERS and inflammation, which reduces kidney damage for mice and have good effect on prolonging its life. It provides a good way for the guidance of clinical research.
Szabo 2-Stent Technique for Coronary Bifurcation Lesions: Procedural and Short-Term Outcomes

Hongbo Yang,Juying Qian,Zheyong Huang,Junbo Ge

DOI: https://doi.org/10.1186/s12872-020-01605-y

IF: 2.174

2020-01-01

BMC Cardiovascular Disorders

Abstract:Provisional 1-stent technique is currently regarded as the default approach for the majority of bifurcation lesions. Nonetheless, 2-stent techniques may be required for complex bifurcations with high compromise risk or fatal consequences of side branch (SB) occlusion. Limitations exist in current approaches, as stents gap, multiple metal layers and stent malapposition caused by imprecise placement with fluoroscopic guide and intrinsic technical defects. This study was designed to investigate the effectiveness of the novel Szabo 2-stent technique for coronary bifurcation lesions. In the Szabo 2-stent technique, one stent is precisely implanted at the SB ostium with Szabo technique resulting in a single strut protruding into the main vessel (MV). After MV rewiring and SB guidewire withdrawal, another stent is implanted in MV followed by proximal optimization technique, SB rewiring, and final kissing inflation (FKI). The technique tested successfully in silicone tubes (n = 9) with: procedure duration, 31.2 ± 6.8 min; MV and SB rewiring time, 26.8 ± 11.2 s and 33.3 ± 15 s; easy FKI; and 2.3 ± 0.5 balloons/procedure. Bifurcation lesions (n = 22) were treated with angiographic success in MV and SB, respectively: increased minimal lumen diameter (0.63 ± 0.32 mm to 3.20 ± 0.35 mm; 0.49 ± 0.37 mm to 2.67 ± 0.25 mm); low residual stenosis (12.4 ± 2.4%; 12.4 ± 2.3%); and intravascular ultrasound confirmed (n = 19) full coverage; minimal overlap and malapposition; minimal lumen area (2.4 ± 1.2 mm2; 2.1 ± 1.0 mm2); plaque burden (78.1 ± 11.3%; 71.6 ± 15.5%); and minimal stent area (9.1 ± 1.6 mm2; 6.1 ± 1.3 mm2). Periprocedural cardiac troponin increased in 1 asymptomatic patient without electrocardiographic change. There was no target lesion failure (cardiac death, myocardial infarction, target lesion revascularization) at 6-month follow-up. The Szabo 2-stent technique for bifurcation lesions provided acceptable safety and efficacy at short-term follow-up.
BIFURCATION STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISTAL LESIONS IN THE DRUG ELUTING STENT ERA: ONE-YEAR CLINICAL FOLLOW-UP RESULTS FROM A SINGLE CENTRE

Liu Hai-Wei,Han Ya-Ling,Jing Quan-Min,Ma Ying-Ya,Wang Geng,Wang Bin,Xu Kai,Guan Shao-Yi

DOI: https://doi.org/10.1136/heartjnl-2013-303992.229

IF: 5.7

2013-01-01

Heart

Abstract:Objectives The unprotected left main coronary artery (ULMCA) bifurcation stenosis remains challenging for percutaneous coronary intervention (PCI). The aim of the study was to evaluate the effectiveness and safety of bifurcation technique on the treatment of ULMCA bifurcation stenosis in drug eluting stent era. Methods Between March 2004 and November 2011, a total of 224 patients (168 male) underwent bifurcation technique with drug eluting stent for true bifurcation lesions of ULMCA. Patients with cardiogenic shock were excluded from the analysis. We defined true bifurcations as Medina 1,1,1 or 1,0,1 or 0,1,1. The indexes of in-hospital, angiographic restenosis at 12-months and major adverse cardiac events (MACE) including cardiac death, myocardial infarction or any target lesion revascularisation were evaluated. Results The procedural was successful in all patients. Bifurcation techniques included T stenting in 78(34.8%), Cullotte stenting in 69(30.8%) and Crush stenting in 77(34.3%) patients. Final “kissing balloon” inflation was preferred in 196 cases (87.5%). Intravascular ultrasound (IVUS) was performed in 79 cases during procedural. The mean stent diameter was (3.4 ± 0.40) mm in ULMCA. The overall rate of MACE was 1.3% (3/224) during hospital stay, including one acute stent thrombosis during procedure and 2 patients underwent repeat angioplasty for subacute stent thrombosis after PCI procedure. One patient died for subacute stent thrombosis during hospital stay. All patients were followed-up for at least 12 months. Two patients died for congestive heart failure during follow-up. Angiographic follow-up was obtained in 96(42.9%) patients. Binary in-stent restenosis occurred in 15(6.7%) patients and all of them were treated with CABG (7/15) or repeat PCI (8/15). The rate of target vessel revascularisation was significantly lower in patients with final kissing inflation during the index procedure compared with those without final kissing (4.1% (8/196) vs 25.0% (7/28); P Conclusions Our experience indicated that bifurcation stenting for LMCA bifurcation lesions in elective patients could achieve a high technical success rate. Final kissing balloon might reduce the need for target vessel revascularisation.
Acute and long-term results of percutaneous coronary intervention of bifurcation lesions with the dedicated Bioss Lim C stent: the Italian BIfurcation Observational Spontaneous Study (IBIOSS)

Carlo Briguori,Davide Capodanno,Marco Contarini,Michael E Donahue,Salvatore Evola,Nadia Garro,Francesco Greco,Alessio LA Manna,Paola Murè,Antonino Nicosia,Giuseppe Migliore,Giorgio Sacchetta,Nicola Signore,Corrado Tamburino,Giampiero Vizzari,Giuseppe Biondi-Zoccai

DOI: https://doi.org/10.23736/S0026-4806.23.08929-2

Abstract:Background: Percutaneous coronary intervention (PCI) for bifurcation lesions still represents a clinical challenge. The Bioss Lim C is a dedicated device for bifurcation lesions, features a tapered shape and large cells, and thus appears as a promising adjunct to the current interventional cardiologists' armamentarium. We aimed at conducting a prospective multicenter study focusing on early and long-term results after Bioss Lim C implantation for true coronary bifurcation lesions. Methods: Patients with true bifurcation lesions in whom Bioss Lim C implantation was attempted were enrolled in four Italian centers. An explicit bifurcation management approach was recommended, leaving however the choice between one- vs. two-stent strategies at operator's discretion. Acute and long-term results were systematically appraised, focusing on an acute composite of complex side branch (SB) rewiring, SB pinching, or SB occlusion (primary efficacy endpoint), as well as major adverse events (MACE, i.e. death, myocardial infarction [MI], or target vessel revascularization [TVR]), individual components of MACE, and stent thrombosis. Results: A total of 207 patients were included, with age of 67.3±10.8 years, and 40 (19.3%) women. The target lesion was located in the left main in 48 (23.2%) patients, whereas proximal reference vessel diameter was 3.69±0.48 mm, and lesion length 20.3±3.4 mm. According to the Medina classification, most patients (60 [30.9%]) had 1-1-1 lesions. Drug-eluting stent implantation in the SB was carried out in 19 (9.3%) subjects, and kissing balloon inflation was used in 67 (32.5%). The primary efficacy endpoint occurred in 27 (13.0%), with side branch (SB) occlusion in two (1.0%), SB pinching in 23 (11.1%), and complex SB rewiring in six (2.9%), and was most frequent in patients with lower body mass index or dyslipidemia. After 24.1±19.5 months, MACE were adjudicated in 23 (11.1%) subjects, with death in 10 (4.8%), MI in six (2.9%), and TVR in seven (3.4%), as well as stent thrombosis in one (0.5%). Conclusions: This study supports a wider adoption of the Bioss Lim C dedicated bifurcation device, thanks to the favorable acute results as well as long-term clinical outcomes, as well as its versatility for the stenting strategy provisionally or eventually adopted by operators.
Mini- Versus Classical Kissing Balloon Inflation in Provisional Technique for Bifurcation Intervention

Jia Liu,Shaoliang Chen,Jianrui Wei,Fang Zeng,Li

DOI: https://doi.org/10.1111/joic.12548

2018-01-01

Journal of Interventional Cardiology

Abstract:Objectives We compared the potential benefits of mini-KBI (M-KBI), an optimized kissing balloon inflation (KBI), and classical KBI (C-KBI) in provisional bifurcation stenting. Background The long-term clinical outcomes of C-KBI in a provisional stenting strategy continue to be under debate due to main vessel (MV) stent deformation and overexpansion. Methods Twelve stents were deployed in a silicone coronary bifurcation model using a provisional stenting strategy: C-KBI (two non-compliant balloons juxtaposed within the MV stent) was performed in six cases, and M-KBI (the side branch (SB) balloon protruded only into the MV at the upper edge of the SB ostium) was performed in the remaining six cases, all of which were followed by proximal optimization technique POT. Stent geometry was evaluated by bench photos, videoscope, micro-CT, microscopy, and intravascular ultrasound (IVUS). Results C-KBI rectified the MV stent malapposition, but resulted in stent deformation, overexpansion and the "bottleneck" effect, which could not be rectified by POT. M-KBI also rectified the MV stent malapposition, without notable stent deformation, overexpansion, or the "bottleneck" effect. POT optimized the MV strut apposition. Conclusions M-KBI, an optimized KBI, is recommended to prevent stent deformation and overexpansion and to optimize stent deployment in a provisional stenting strategy.
Safety and Efficacy of a Hybrid Approach Combining a Paclitaxel-Coated Balloon With a New Generation Drug-Eluting Stent in Patients With De Novo True Coronary Bifurcation Lesions

Sami Kasbaoui,Laurent Payot,Amer Zabalawi,Regis Delaunay,Wael Ben Amara,Marouane Boukhris,Guillaume Taldir

DOI: https://doi.org/10.1016/j.carrev.2023.04.010

Abstract:Background: The use of drug-coated balloon in the management of true bifurcation lesions appears to be an attractive option to reduce the rate of stent thrombosis and restenosis particularly at the level of the side branch ostium. We aim to assess the safety and the efficacy of a hybrid approach combining a drug-eluting stent in the main branch and a drug-coated balloon to treat the side branch ostium in patients with de novo true bifurcation. Methods: From September 2020 to March 2022, 45 patients with a de novo true bifurcation lesion Medina (1.1.1) or Medina (0.1.1) were enrolled. All patients underwent a percutaneous coronary intervention with the hybrid approach. Clinical assessment with functional stress imaging test was scheduled at 6 months. In case of documented ischemia, coronary angiography was performed. The primary endpoint was the composite of target lesion failure at 6 months including cardiac death, target vessel MI or ischemia-driven target lesion revascularization. The secondary endpoints were technical success, defined by performing the percutaneous coronary intervention without an additional drug-eluting stent at the level of the side branch ostium, and clinical success, defined by a technical success associated with the absence of severe complications during in-hospital phase. Results: The immediate results show a technical success of the procedure in the majority of cases (88.9 %) with a low rate of bailout side branch stenting (11.1 %). The clinical success was obtained in 86.7 % and only one patient experienced a severe in-hospital complication. A side branch ostial lesion length > 10 mm was the only independent predictor of clinical failure of the procedure (OR 12.49, 95 % CI 1.17-133.6; p = 0.037). At 6 months, the TLF was low and occurred in 1 patient (2.2 %). No cardiac death was observed. No TVMI was observed. Importantly, at 6 months, no side branch thrombosis was observed. Conclusion: The use of a hybrid approach combining a drug-eluting stent in the main branch and a drug-coated balloon in the side branch to treat true bifurcation lesions appears to be safe and efficient with few immediate complications and with satisfactory results at mid-term follow up.
Nucleotide sequence and structural organization of an insertion sequence element (IS231) from Bacillus thuringiensis strain berliner 1715.

J. Mahillon,J. Seurinck,L. Rompuy,J. Delcour,M. Zabeau

DOI: https://doi.org/10.1002/j.1460-2075.1985.tb04163.x

1985-12-01

Abstract:This paper describes the structural organization of a repetitive DNA sequence isolated from plasmids of Bacillus thuringiensis strain berliner 1715. DNA sequence analysis of this repetitive sequence (RS) revealed all the characteristic features of an insertion sequence (IS). This 1656‐bp element is delineated by two 20‐bp inverted repeats which are flanked by two 11‐bp direct repeats. A long open reading frame spans almost the entire sequence and is preceded by potential transcriptional and translational signals. A structural homology was observed between this RS and the Escherichia coli IS4 element in the length of their direct repeats, the sequence of their inverted repeats and the sequence of their putative transposases. These data strongly suggest that this sequence is an authentic insertion sequence. Therefore the name IS231 is proposed for this first Bacillus IS element. Further relationships with other known IS sequences were also found and are discussed.

Almost periodic solutions for a class of Liénard-type systems with continuously distributed delays

Clinical Observation of Simple Drug Coated Balloon Angioplasty in the Treatment of Coronary Bifurcation Lesions

[Treatment of coronary bifurcation lesions with 6F-guiding catheter by transradial approach].

Effect of Balloon Embedded Bifurcating Stenting with Single Stent Strategy for Side Branch Protection

Immunodepression by oncogenic viruses.

Drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation lesions: 4-years follow-up

A Novel Strategy to Simplify the Procedures in Treating Complicated Coronary Bifurcation Lesions: From a Bench Test to Clinical Application

Impact of stent strut link location in proximal balloon edge dilation technique for bifurcation percutaneous coronary intervention

Novel Side Branch Ostial Stent (biguard (tm)): First-In-Man Study

Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trial

Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: the Multicenter Randomized DCB-BIF Trial.

Acute Angiographic and Intermediate-Term Clinical Results of Patients with Non-Left Main Coronary Bifurcation Lesions Treated with BVS by Jailed Semi-Inflated Balloon Technique and Provisional Side-Branch Stenting Strategy

Modified Kissing Balloon Inflation Associated with Better Results after Culotte Stenting for Bifurcation Lesions: A Bench Test

A Drug-Eluting Balloon for the Treatment of Coronary Bifurcation Lesions in the Side Branch: a Prospective Multicenter Randomized (BEYOND) Clinical Trial in China

Effect of low-dose cyclophosphamide on endoplasmic reticulum stress and inflammatory reaction of acute renal ischemia reperfusion injury.

Szabo 2-Stent Technique for Coronary Bifurcation Lesions: Procedural and Short-Term Outcomes

BIFURCATION STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISTAL LESIONS IN THE DRUG ELUTING STENT ERA: ONE-YEAR CLINICAL FOLLOW-UP RESULTS FROM A SINGLE CENTRE

Acute and long-term results of percutaneous coronary intervention of bifurcation lesions with the dedicated Bioss Lim C stent: the Italian BIfurcation Observational Spontaneous Study (IBIOSS)

Mini- Versus Classical Kissing Balloon Inflation in Provisional Technique for Bifurcation Intervention

Safety and Efficacy of a Hybrid Approach Combining a Paclitaxel-Coated Balloon With a New Generation Drug-Eluting Stent in Patients With De Novo True Coronary Bifurcation Lesions

Nucleotide sequence and structural organization of an insertion sequence element (IS231) from Bacillus thuringiensis strain berliner 1715.